Rapport Therapeutics, Inc. RAPP Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s accrued expenses and other liabilities?
- Rapport Therapeutics, Inc. (RAPP) reported accrued expenses and other liabilities of -$3.49M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s accrued expenses and other liabilities changed year-over-year?
- Rapport Therapeutics, Inc.'s accrued expenses and other liabilities decreased by 1154.7% year-over-year, from $331K to -$3.49M.